Key facts
- This page summarizes Michele Santana's Form 4 filing for TransDigm Group INC (TDG).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Nov 2026, 17:09.
Michele Santana - 03 Nov 2026 Form 4 Insider Report for TransDigm Group INC (TDG)
- Reporting relationship
- Director
- Issuer ticker
- TDG
- Reported as of
- 03 Nov 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Nov 2026, 17:09:55 UTC
- Prior SEC filing
- 21 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rachel L. Quinlan as attorney in fact for Michele Santana
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Michele Santana filed Form 4 for TransDigm Group INC (TDG) on 05 Nov 2026.
Change
- Previous filing in this sequence was filed on 21 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001615382
Primary reporting owner
Santana Michele
- Relationship
- Director
- Address
- 3469 AEGEAN RD, AKRON
- Signature
- /s/ Rachel L. Quinlan as attorney in fact for Michele Santana
- Signature date
- 05 Nov 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TDG
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +589
- Change %
- Price
- $0.000000*
- Shares after
- 589
- Date
- 03 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 589
- Exercise price
- $1208.04
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year.